Drug repurposing, also known as drug repositioning or reprofiling, refers to the process of
identifying new therapeutic applications for existing drugs that were originally intended for …

Drug repurposing for cancer therapy is currently a hot topic of research. Theoretically, in
contrast to the known hurdles of developing new molecular entities, the approach of …

Alzheimer's disease (AD) is the most common form of neurodegenerative dementia,
affecting about 30 million people worldwide. Despite recent advances in understanding its …

Highlights•Drug repurposing gained momentum in the recent past.•Drug repurposing is a
promising strategy for rare disease drug discovery.•Drug repurposing resulted in fruitful …

Drug repurposing is a strategy that aims to develop novel cancer treatments through the
reuse of existing medicines developed in other disease areas. Such a strategy includes the …

Because of the high risk, substantial cost and slow pace of new drug discovery and
development, drug repurposing (also called repositioning, redirecting, reprofiling) is …

Repurposing refers to the therapeutic use of a drug or drug candidate for a disease other
than that for which it was originally intended. Repurposing is attractive as a drug …

Repurposing drugs requires finding novel therapeutic indications compared to the ones for
which they were already approved. This is an increasingly utilized strategy for finding novel …

The exploration and identification of new anti-cancer therapeutic indications for an approved
drug already in use, or for a drug that was shelved for non-safety reasons in early clinical …

Current drug development strategies devote extensive effort to identifying the molecular
mechanism of action of new drug candidates. Often, if more than one unrelated enzyme or …